Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis

References

• StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuv -ant temozolomide for glioblastomaN Engl J Med20053521098799615758009
   PubMed Web of Science ®Google Scholar
• HegiMELiuLHermanJGCorrelation of O6-methylguanine methyl-transferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activityJ Clin Oncol200826254189419918757334
   PubMed Web of Science ®Google Scholar
• VerbeekBSouthgateTDGilhamDEMargisonGPO6-Methylguanine- DNA methyltransferase inactivation and chemotherapyBr Med Bull200885173318245773
   PubMed Web of Science ®Google Scholar
• GersonSLClinical relevance of MGMT in the treatment of cancerJ Clin Oncol20022092388239911981013
   PubMed Web of Science ®Google Scholar
• EstellerMGarcia-FoncillasJAndionEInactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsN Engl J Med2000343191350135411070098
   PubMed Web of Science ®Google Scholar
• BobolaMSBergerMSEllenbogenRGRobertsTSGeyerJRSilberJRO6-Methylguanine-DNA methyltransferase in pediatric primary brain tumors: relation to patient and tumor characteristicsClin Cancer Res20017361311297257
   PubMed Web of Science ®Google Scholar
• FriedmanHSMcLendonREKerbyTDNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant gliomaJ Clin Oncol19981612385138579850030
   PubMed Web of Science ®Google Scholar
• WellerMStuppRReifenbergerGMGMT promoter methylation in malignant gliomas: ready for personalized medicine?Nat Rev Neurol200961395119997073
   PubMed Web of Science ®Google Scholar
• ShilpaVBhagatRPremalataCSPallaviVRRameshGKrishnamoorthyLRelationship between promoter methylation & tissue expression of MGMT gene in ovarian cancerIndian J Med Res2014140561662325579142
   PubMed Web of Science ®Google Scholar
• FelsbergJRappMLoeserSPrognostic significance of molecular markers and extent of resection in primary glioblastoma patientsClin Cancer Res200915216683669319861461
   PubMed Web of Science ®Google Scholar
• SciuscioDDiserensDvan DommelenDMartinetDJonesDJanzerDExtent and patterns of MGMT promoter methylation in glioblastoma-and respective glioblastoma-derived spheresClinical Cancer Research An Official Journal of the American Association for Cancer Research20111725526621097691
   PubMed Web of Science ®Google Scholar
• BrellMTortosaAVergerEPrognostic significance of O6-methylguanine-DNA methyl-transferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomasClin Cancer Res200511145167517416033832
   PubMed Web of Science ®Google Scholar
• GorliaTvan den BentMJHegiMENomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981–22981/CE.3Lancet Oncol200891293818082451
   PubMed Web of Science ®Google Scholar
• SpruanceSLReidJEGraceMSamoreMHazard ratioin clinical trialsAntimicrob Agents Chemother20044882787279215273082
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDPractical methods for incorporating summary time-to-event data into metaanalysisTrials2007811617555582
   PubMed Web of Science ®Google Scholar
• CohenJFChalumeauMCohenRKorevaarDAKhoshnoodBBossuytPMCochran’s Q test was useful to assess heterogeneity in likelihood ratios instudies of diagnostic accuracyJ Clin Epidemiol201568329930625441698
   PubMed Web of Science ®Google Scholar
• DeeksJJAltmanDGChapter 9 analysing data and undertaking meta-analysesCochrane Handbook for Systematic Reviews of Interventions Version 5.1.02011 Available from: http://xueshu.baidu.com/s?wd=paperuri%3A%2893155479b8a8f47eb878935af3cf9292%29&filter=sc_long_sign&tn=SE_xueshusource_2kduw22v&sc_vurl=http%3A%2F%2Fonlinelibrary.wiley.com%2Fresolve%2Freference%2FXREF%3Fid%3D10.1002%2F9780470712184.ch9&ie=utf-8&sc_us=13279804406616589552Accessed August 29, 2017
   Google Scholar
• HigginsJPThompsonSGQuantifying heterogeneity in a metaanalysisStat Med200221111539155812111919
   PubMed Web of Science ®Google Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• TangKJinQYanWClinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patientsMed Oncol20122921292129621394635
   PubMed Web of Science ®Google Scholar
• MotomuraKNatsumeAKishidaYBenefits of interferon-beta and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: a multicenter studyCancer201111781721173021472719
   PubMed Web of Science ®Google Scholar
• EtcheverryAAubryMde TayracMDNA methylation in glioblastoma: impact on gene expression and clinical outcomeBMC Genomics201011170121156036
   PubMed Web of Science ®Google Scholar
• VillaniVCasiniBPaceAThe prognostic value of pyrosequencing-detected MGMT promoter hypermethylation in newly diagnosed patients with glioblastomaDis Markers2015201560471926347581
   PubMed Web of Science ®Google Scholar
• GutenbergABockHCReifenbergerGBrückWGieseAToxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysisActa Neurochir (Wien)2013155342943523254891
   PubMed Web of Science ®Google Scholar
• AdebergSBostelTHarrabiSImpact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastomaBMC Cancer20151555826223282
   PubMed Web of Science ®Google Scholar
• KimYSKimSHChoJMGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a Single-Institution StudyInt J Radiat Oncol Biol Phys201284366166722414280
   PubMed Web of Science ®Google Scholar
• Lechapt-ZalcmanELevalletGDugueAEO(6)-Methylguanine-DNA methyl-transferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomideCancer2012118184545455422359215
   PubMed Web of Science ®Google Scholar
• ReifenbergerGHentschelBFelsbergJPredictive impact of MGMT promoter methylation in glioblastoma of the elderlyInt J Cancer2011131613421350
   Web of Science ®Google Scholar
• FelsbergJThonNEigenbrodSPromoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomasInt J Cancer2011129365967021425258
   PubMed Web of Science ®Google Scholar
• BalanaCCarratoCRamirezJLTumour and serum MGMT promoter methylation and protein expression in glioblastoma patientsClin Transl Oncol201113967768521865140
   PubMed Web of Science ®Google Scholar
• LakomyRSanaJHankeovaSMiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patientsCancer Sci2011102122186219021895872
   PubMed Web of Science ®Google Scholar
• SonodaYYokosawaMSaitoRO(6)-Methylguanine DNA methyl-transferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastomaInt J Clin Oncol201015435235820232102
   PubMed Web of Science ®Google Scholar
• MinnitiGSalvatiMArcellaACorrelation between O6-methyl-guanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radio-therapy plus concomitant and adjuvant temozolomideJ Neurooncol2011102231131620686820
   PubMed Web of Science ®Google Scholar
• ThonNEigenbrodSGrasbon-FrodlEMPredominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomideJ Neurol Neurosurg Psychiatry201182444144620861061
   PubMed Web of Science ®Google Scholar
• WellerMFelsbergJHartmannCMolecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma NetworkJ Clin Oncol200927345743575019805672
   PubMed Web of Science ®Google Scholar
• WemmertSBettscheiderMAltSp15 promoter methylation—a novel prognostic marker in glioblastoma patientsInt J Oncol20093461743174819424593
   PubMed Web of Science ®Google Scholar
• HegiMEDiserensACGodardSClinical trial substantiates the predictive value of O-6- methylguanine -DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomideClin Cancer Res20041061871187415041700
   PubMed Web of Science ®Google Scholar
• ZawlikIVaccarellaSKitaDMittelbronnMFranceschiSOhgakiHPromoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based studyNeuroepidemiology2009321212918997474
   PubMed Web of Science ®Google Scholar
• ParkCKParkSHLeeSHMethylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatinNeuropathology200929444344919170894
   PubMed Web of Science ®Google Scholar
• SonodaYKumabeTWatanabeMLong-term survivors of glioblastoma: clinical features and molecular analysisActa Neurochir2009151111349135819730774
   PubMed Web of Science ®Google Scholar
• MetellusPCoulibalyBNanniIPrognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohortCancer2009115204783479419637364
   PubMed Web of Science ®Google Scholar
• CaoVTJungTYJungSThe correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomasNeurosurgery200965586687519834398
   PubMed Web of Science ®Google Scholar
• IaccarinoCOrlandiERuggeriFPrognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapyClin Neurol Neurosurg20151321825723791
   PubMed Web of Science ®Google Scholar
• BaraultLAmatuABleekerFEDigital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancerAnn Oncol20152691994199926113646
   PubMed Web of Science ®Google Scholar
• ShenDLiuTLinQMGMT promoter methylation correlates with an overall survival benefit in Chinese high-grade glioblastoma patients treated with radiotherapy and alkylating agent-based chemotherapy: a single-institution studyPLoS One201499e10755825211033
   PubMed Web of Science ®Google Scholar
• MelguizoCPradosJGonzálezBMGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapyJ Transl Med201210125023245659
   PubMed Web of Science ®Google Scholar
• KanemotoMShirahataMNakaumaAPrognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter regionBMC Cancer201414164125175833
   PubMed Web of Science ®Google Scholar
• ChristiansAHartmannCBennerAPrognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastomaPLoS One201273e3344922428052
   PubMed Web of Science ®Google Scholar
• CombsSERiekenSWickWPrognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward and one step back?Radiat Oncol20116111521910919
   PubMed Web of Science ®Google Scholar
• YangSHLeeKSYangHJO(6)-Methylguanine-DNA-methyltransferase promoter methylation assessment by microdissection-assisted methylation-specific PCR and high resolution melting analysis in patients with glioblastomasJ Neurooncol2012106224325021792731
   PubMed Web of Science ®Google Scholar
• EllingsonBMCloughesyTFPopeWBAnatomic localization of O6-methylguanine DNA methyl- transferase (MGMT) promoter methylated and unmethylated tumors: a radio-graphic study in 358 de novo human glioblastomasNeuroimage201259290891622001163
   PubMed Web of Science ®Google Scholar
• ParkCKKimJYimSYUsefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patientsNeuro Oncol201113219520221075779
   PubMed Web of Science ®Google Scholar
• CostaBMCaeiroCGuimaraesIPrognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide- based chemoradiation: a Portuguese multicentre studyOncol Rep20102361655166220428822
   PubMed Web of Science ®Google Scholar
• BrandesAAFranceschiETosoniAO(6)-Methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implicationsNeuro Oncol201012328328820167816
   PubMed Web of Science ®Google Scholar
• MorandiLFranceschiEde BiaseDPromoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a referenceBMC Cancer20101014820167086
   PubMed Web of Science ®Google Scholar
• RiveraALPelloskiCEGilbertMRMGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaNeuro Oncol201012211612120150378
   PubMed Web of Science ®Google Scholar
• ZunarelliEBigianiNSartoriGMigaldiMSgambatoAMaioranaAINI1 immuno-histochemical expression in glioblastoma: correlation with MGMT gene promoter methylation status and patient survivalPathology2011431172321240060
   PubMed Web of Science ®Google Scholar
• Karayan-TaponLQuillienVGuilhotJPrognostic value of O6-methyl-guanine-DNA methyl -transferase status in glioblastoma patients, assessed by five different methodsJ Neurooncol201097331132219841865
   PubMed Web of Science ®Google Scholar
• BrandesAAFranceschiETosoniATemozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation statusCancer2009115153512351819514084
   PubMed Web of Science ®Google Scholar
• SmithKAAshbyLSGonzalezLFProspective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiformeJ Neurosurg2008109suppl10611719123896
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• QuillienVLavenuASansonMOutcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patientsJ Neurooncol2014116348749624420923
   PubMed Web of Science ®Google Scholar
• CitronMDeckerRChenSO6-Methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovaryCancer Res19915116413141341868433
   PubMed Web of Science ®Google Scholar
• SilberJRMuellerBAEwersTGBergerMSComparison of O6-methyl-guanine-DNA methyltransferase activity in brain tumors and adjacent normal brainCancer Res19935314341634208324751
   PubMed Web of Science ®Google Scholar
• ThonNKrethSKrethFWPersonalized treatment strategies in glioblastoma: MGMT promoter methylation statusOnco Targets Ther201361363137224109190
   PubMed Web of Science ®Google Scholar
• WickWPlattenMMeisnerCTemozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialLancet Oncol201213770771522578793
   PubMed Web of Science ®Google Scholar
• MalmströmAGrønbergBHMarosiCTemozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trialLancet Oncol201213991692622877848
   PubMed Web of Science ®Google Scholar
• HegiMEDiserensACGorliaTMGMT gene silencing and benefit from temozolomide in glioblastomaN Engl J Med200535210997100315758010
   PubMed Web of Science ®Google Scholar
• GersonetSLMGMT: its role in cancer aetiology and cancer therapeuticsNat Rev Cancer20044429630715057289
   PubMed Web of Science ®Google Scholar
• ZhaoHWangSSongCZhaYLiLThe prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysisWorld J of Surg Oncol20161426127733166
   PubMed Web of Science ®Google Scholar
• ChakravartiAErkkinenMGNestlerUTemozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanismsClin Cancer Res200612154738474616899625
   PubMed Web of Science ®Google Scholar
• FianoVTrevisanMTrevisanEMGMT promoter methylation in plasma of glioma patients receiving temozolomideJ Neurooncol2014117234735724519517
   PubMed Web of Science ®Google Scholar
• McDonaldKLRapkinsRWOlivierJThe T genotype of the MGMT C[T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patientsEur J Cancer201349236036822975219
   PubMed Web of Science ®Google Scholar
• ChenCHuangRMacLeanARecurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survivalJ Neurooncol2013115226727623974656
   PubMed Web of Science ®Google Scholar
• OchsenbeinAFSchubertADVassellaEMarianiLQuantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomasJ Neurooncol2011103234335120857319
   PubMed Web of Science ®Google Scholar
• StuppRHegiMEGorliaTCilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trialLancet Oncol201415101100110825163906
   PubMed Web of Science ®Google Scholar
• GlasMHappoldCRiegerJLong-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolo-mideJ Clin Oncol20092781257126119188676
   PubMed Web of Science ®Google Scholar
• PradosMDChangSMButowskiNPhase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcomaJ Clin Oncol200927457958419075262
   PubMed Web of Science ®Google Scholar
• DunnJBaborieAAlamFExtent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapyBr J Cancer2009101112413119536096
   PubMed Web of Science ®Google Scholar
• MuratAMigliavaccaEGorliaTStem cell-related ‘‘self-renewal’’ signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastomaJ Clin Oncol200826183015302418565887
   PubMed Web of Science ®Google Scholar
• YangHWeiDYangKTangWLuoYZhangJThe prognosis of MGMT promoter methylation in glioblastoma patients of different race:a meta-analysisNeurochem Res2014391211124258018
   PubMed Web of Science ®Google Scholar
• AbhinavKAquilinaKGbejuadeHLaMHopkinsKIyerVA pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survivalClin Neurol Neurosurg201311581375137823333005
   PubMed Web of Science ®Google Scholar
• SkiriuteDVaitkienePSaferisVMGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastomaBMC Cancer20121221822672670
   PubMed Web of Science ®Google Scholar
• CarrilloJALaiANghiemphuPLRelationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastomaAJNR Am J Neuroradiol20123371349135522322613
   PubMed Web of Science ®Google Scholar
• OhkaFNatsumeAMotomuraKWakabayashi The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for gliomaPLoS One201168e2333221829728
   PubMed Web of Science ®Google Scholar
• WickWHartmannCEngelCNOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomideJ Clin Oncol200927355874588019901110
   PubMed Web of Science ®Google Scholar
• Van den BentMJDubbinkHJSansonMMGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951J Clin Oncol200927355881588619901104
   PubMed Web of Science ®Google Scholar
• StuppRHegiMEMasonWPEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialLancet Oncol200910545946619269895
   PubMed Web of Science ®Google Scholar
• SchaichMKestelLPfirrmannMMDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patientsAnn Oncol200920117518118687982
   PubMed Web of Science ®Google Scholar
• GerstnerERYipSWangDLLouisDNIafrateAJBatchelorTTMgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastomaNeurology200973181509151019884580
   PubMed Web of Science ®Google Scholar
• EoliMMenghiFBruzzoneMGMethylation of O6- methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survivalClin Cancer Res20071392606261317473190
   PubMed Web of Science ®Google Scholar
• WatanabeTKatayamaYKomineCO6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astro-cytomas and their relationships with clinical courseInt J Cancer2005113458158715455376
   PubMed Web of Science ®Google Scholar
• ThonNThorsteinsdottirJEigenbrodSOutcome in unresectable glioblastoma:MGMT promoter methylation makes the differenceJ Neurol2017264235035827921166
   PubMed Web of Science ®Google Scholar
• GerstnerERDudaDGdi TomasoEVEGF inhibitors in the treatment of cerebral edema in patients with brain cancerNat Rev Clin Oncol20096422923619333229
   PubMed Web of Science ®Google Scholar
• ChengWLiMCaiJA prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylationJ Neurooncol2015122230331225557107
   PubMed Web of Science ®Google Scholar